Abstract
Large cell neuroendocrine carcinoma is not very common, and it has a high degree of malignancy and invasion, outcome is also poor. Even LCLC is defined as non-small cell lung cancer, its biological and clinical characteristics, prognostic factors are similar to small cell lung cancer. The treatment for LCLC is still controversial. The research progress on comprehensive treatment of lung large cell neuroendocrine carcinoma was reviewed. Key words: Lung large cell neuroendocrine carcinoma/combined modality therapy; Progression
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.